Docetaxel Mechanism of Action: Microtubule Inhibition in Prostate Cancer Cell Research

Docetaxel MOA:Targeting Microtubule/Androgen Receptor Signaling Pathway for Castration-Resistant Prostate Cancer

🎯 check Docetaxel product page

Docetaxel is a potent microtubule stabilizer. It affects PI3K/Akt/mTOR and apoptosis-related signaling pathways. By binding to microtubules with high affinity and disrupting microtubule dynamics, it induces G2/M cell cycle arrest, thereby inhibiting tumor cell proliferation, migration, and promoting apoptosis.

Primary Applications and Mechanism of Action